ABSTRACT
ABSTRACT: 68 Ga-DOTATATE PET/CT is a well-known modality in diagnosis, staging, and in predicting therapy response of neuroendocrine tumors. We present a case of 63-year-old woman with diagnosis of pancreas neuroendocrine tumor showing 68 Ga-DOTATATE uptake in a lymph node in left axilla. It was diagnosed as capillary hemangioma after biopsy. 68 Ga-DOTATATE uptake in bone hemangiomas is well-known; however, its uptake in a nodal hemangioma is worth to know as it might change the clinical perspective.
Subject(s)
Hemangioma , Neuroendocrine Tumors , Organometallic Compounds , Axilla/pathology , Female , Hemangioma/diagnostic imaging , Humans , Lymph Nodes/pathology , Middle Aged , Neuroendocrine Tumors/pathology , Positron Emission Tomography Computed Tomography , Positron-Emission Tomography , Radionuclide Imaging , Radiopharmaceuticals , Tomography, X-Ray ComputedABSTRACT
ABSTRACT: We report 3 patients with COVID-19 findings in 68Ga-PSMA PET/CT taken for staging. The first patient, A 64-year-old man with prostate cancer, who had COVID-19 in November 2020 and whose treatment was completed, was observed to continue with COVID-19 findings in 68Ga-PSMA PET/CT in December 2020 before surgery. Other patients were asymptomatic for the disease. It was determined that a PSMA uptake in the lungs corresponding to the CT findings of COVID-19 had increased in 68Ga-PSMA PET/CT.
